Oregon Public Employees Retirement Fund Acquires 130 Shares of Danaher Co. (NYSE:DHR)

Oregon Public Employees Retirement Fund lifted its holdings in shares of Danaher Co. (NYSE:DHRFree Report) by 0.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 55,107 shares of the conglomerate’s stock after purchasing an additional 130 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in Danaher were worth $12,650,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. AMF Tjanstepension AB acquired a new position in shares of Danaher during the 3rd quarter valued at about $5,923,000. Howard Capital Management Group LLC boosted its position in Danaher by 4.1% during the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after purchasing an additional 48 shares during the period. Allworth Financial LP grew its holdings in Danaher by 6.1% during the third quarter. Allworth Financial LP now owns 5,337 shares of the conglomerate’s stock valued at $1,484,000 after purchasing an additional 307 shares during the last quarter. Arkadios Wealth Advisors lifted its stake in shares of Danaher by 1.8% in the third quarter. Arkadios Wealth Advisors now owns 3,572 shares of the conglomerate’s stock worth $993,000 after buying an additional 64 shares during the last quarter. Finally, Inscription Capital LLC boosted its holdings in shares of Danaher by 75.5% during the 3rd quarter. Inscription Capital LLC now owns 1,981 shares of the conglomerate’s stock worth $551,000 after buying an additional 852 shares during the period. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on DHR shares. The Goldman Sachs Group set a $250.00 target price on shares of Danaher in a research report on Wednesday, January 15th. Scotiabank started coverage on Danaher in a research note on Monday, December 23rd. They set a “sector perform” rating and a $265.00 target price for the company. Robert W. Baird dropped their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. JPMorgan Chase & Co. cut their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Finally, Wells Fargo & Company lowered their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Check Out Our Latest Research Report on DHR

Danaher Price Performance

Danaher stock opened at $210.65 on Wednesday. The business has a 50 day simple moving average of $225.79 and a 200 day simple moving average of $246.04. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The company has a market capitalization of $150.56 billion, a PE ratio of 39.90, a price-to-earnings-growth ratio of 2.66 and a beta of 0.83. Danaher Co. has a one year low of $196.80 and a one year high of $281.70.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the firm earned $2.09 earnings per share. On average, sell-side analysts forecast that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.61%. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio is currently 24.24%.

Insider Transactions at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 11.10% of the company’s stock.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.